echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > NK cell joints (TriKE™ treat breast and gastrointestinal cancers

    NK cell joints (TriKE™ treat breast and gastrointestinal cancers

    • Last Update: 2021-01-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Natural killer cells (NK) are important immune cells in the body, not only related to anti-tumor, antiviral infection and immunomodulation, but also in some cases involved in hypersensitivity and the occurrence of autoimmune diseases, can identify target cells.
    immuno-oncology company GT Biopharma announced today that it has filed a U.S. and international patent application and has initiated clinical development of NK Cell Joint (TriKE™) to treat HER2 plus, HER3 plus and HER2 plus / HER3 plus breast and gastrointestinal cancer.
    NK Cell Joint (TriKE™) consists of a single-chain trisexual scFv recombinant fusion protein affix, which consists of heavy chain and light chain variable zones resistant to CD16 and HER2 antibodies, as well as an improved form of IL-15.
    part of human IL-15 provides a self-sustaining signal of natural killer (NK) cells that activates NK cells and enhances their ability to kill cancer cells.
    The TriKE™ has shown good results in animal models, enabling us to start clinical trials and start GMP production," commented Anthony Cataldo, Chairman and CEO of GT Biopharma.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.